BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Press Releases

  Oncolytics Biotech® to Present New Mechanistic and Translational Data Supporting Pelareorep as an Immune-Priming Backbone at AACR 2026

  March 19, 2026

   · 

  9 min read
• Press Releases

  LivaNova Receives U.S. Food and Drug Administration Premarket Approval for aura6000 System to treat Moderate to Severe Obstructive Sleep Apnea

  March 19, 2026

   · 

  6 min read
• Press Releases

  Adagio Medical Highlights Recent Successful Expanded Access Cases with vCLAS™ System, Including Patients with Premature Ventricular Contractions (PVC)

  March 19, 2026

   · 

  6 min read
• Press Releases

  Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer

  March 19, 2026

   · 

  4 min read
• Press Releases

  Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors

  March 19, 2026

   · 

  3 min read
• Press Releases

  ImmunoBrain Presents Clinical Data for First Immune Checkpoint Therapy Approach in Alzheimer’s Disease at AD/PD™ 2026

  March 19, 2026

   · 

  4 min read
• Press Releases

  Massive Bio Launches NexusPulse™, the Real-Time AI Signal Engine for Oncology Markets

  March 19, 2026

   · 

  3 min read
• Press Releases

  Model Medicines to Present Ultra-Large Virtual Screening and Agentic AI Breakthroughs at AI Convergence: Small Molecule Discovery Summit

  CEO, Daniel Haders II, PhD, to address the inference throughput barrier in AI-driven drug discovery and lead a roundtable on deploying LLMs and AI agents to navigate the multi-parameter optimization challenge in small molecule drug design

  March 19, 2026

   · 

  1 min read
• Press Releases

  Genoskin Showcases HypoSkin® Ex Vivo Platform at SOT Annual Meeting

  ● Findings from collaboration with global immunology company argenx show HypoSkin as translational human-based New Approach Methodology (NAM) platform ● SOT 2026 poster on early local tolerance screening demonstrates potential to reduce reliance on animal testing

  March 19, 2026

   · 

  1 min read
• Press Releases

  START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe

  Partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research

  March 19, 2026

   · 

  1 min read